Richard M. Silver

ORCID: 0000-0002-2038-3278

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy”.

Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapy

Lara D. Veeken(2022)10.1093/rheumatology/keac015

N/A

0.607DataRank · unranked

10 citations

Jan Storek, Rob Woolson, Ashley Pinckney, Lynnette Keyes-Elstein, Paul K. Wallace +21 more

Belumosudil in diffuse cutaneous systemic sclerosis: a randomized, double-blind, open-label extension, placebo-controlled, phase 2 study

Lara D. Veeken(2025)10.1093/rheumatology/keaf062

N/A

0.281DataRank · unranked

4 citations

Richard M. Silver, Virginia Steen, Daniel E. Furst, Flavia V. Castelino, Marcin A. Trojanowski +10 more

Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controlled trials

The Lancet Rheumatology(2022)10.1016/s2665-9913(22)00193-x

N/A

0DataRank · unranked

31 citations

Donald P Tashkin, Richard M. Silver, Carol Feghali Bostwick, Shervin Assassi, DeAnna Baker Frost +6 more

Pathologic differences between systemic sclerosis–associated and idiopathic pulmonary arterial hypertension

Journal of Scleroderma and Related Disorders(2024)10.1177/23971983241296721

N/A

0DataRank · unranked

5 citations

Russell A. Harley, J. Williams, Jessica A. Forcucci, Viswanathan Ramakrishnan, Charlie Strange +4 more

Racial variability in immune responses only partially explains differential systemic sclerosis disease severity

Annals of the Rheumatic Diseases(2024)10.1136/ard-2023-225458

N/A

0DataRank · unranked

5 citations

Ji Soo Kim, Adrianne Woods, G. Leatherman, Laura Gutierrez‐Alamillo, Maureen D. Mayes +18 more

Treatment of Systemic Sclerosis–associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine(2023)10.1164/rccm.202306-1113st

N/A

0DataRank · unranked

164 citations

Sydney B. Montesi, Richard M. Silver, Tanzib Hossain, Madalina Macrea, Derrick Herman +19 more

Critical Role of LMCD1 in Promoting Profibrotic Characteristics of Lung Myofibroblasts in Experimental and Scleroderma‐Associated Lung Fibrosis

Arthritis & Rheumatology(2022)10.1002/art.42344

N/A

0DataRank · unranked

20 citations

Ilia Atanelishvili, Andrew M. Bogatkevich, Richard M. Silver, Galina S. Bogatkevich